Prolonged parvovirus B19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy

Gynecologic and Obstetric Investigation

Volumn 63, Issue 1, 2007, Pages 53-54

  Dobec, Marinko ^a   Juchler, Antoinette ^b   Flaviano, Alois ^a   Kaeppeli, Franz ^a  

^a Medica   (Switzerland)

^b NONE

Author keywords

Erythema infectiosum; Parvovirus B19 infection; Persistent infection; Pregnancy; Prolonged viremia

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; BLOOD SAMPLING; CASE REPORT; DELIVERY; DISEASE COURSE; ERYTHEMA INFECTIOSUM; FEMALE; HUMAN; IMMUNOBLOTTING; INFECTION; INTRAUTERINE INFECTION; NEWBORN PERIOD; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIMARY INFECTION; PRIORITY JOURNAL; SEROCONVERSION; SEROLOGY; UMBILICAL CORD BLOOD; VIREMIA; VIRUS DETECTION;

ADULT; ANTIBODIES, VIRAL; ERYTHEMA INFECTIOSUM; FEMALE; HUMANS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIREMIA;

EID: 33845930091     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095394     Document Type: Article

References (4)

1. Morita E, Nakashima A, Asao H, Sato H, Sugamura K: Human parvovirus B19 non-structural protein (NS1) induces cell cycle arrest at G(1) phase. J Virol 2003;77:2915-2921.
2. Cassinotti P, Schultze D, Wieczorek K, Schonenberger R, Siegl G: Parvovirus B19 infection during pregnancy and development of hydrops fetalis despite the evidence for pre-existing anti-B19 antibody: How reliable are serological results? Clin Diagn Virol 1994;2:87-94.
3. Lefrere JJ, Servant-Delmas A, Candotti D, Mariotti M, Thomas I, Brossard Y, Lefrere F, Girot R, Allain JP, Laperche S: Persistent B19 infection in immunocompetent individuals: Implication for transfusion safety. Blood 2005;106:2890-2895.
4. Dorsch S, Kaufmann B, Schaible U, Prohaska E, Wolf H, Modrow S: The VP1-unique region of parvovirus B19:amino acid variability and antigenic stability. J Gen Virol 2001;82:191-199.